Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
HR Manager Location: San José, Costa Rica This role is based at our San José Shared Service Center, where you will partner closely with business leaders to shape people strategies that support operational excellence and future growth.
Work ScheduleFirst Shift (Days) Environmental ConditionsOffice Job Description Commercial Solutions Manager – Drug Delivery Device SME Job Type: Full Time; Fully Remote As part of the Thermo Fisher Scientific team, youll discover meaningful work that makes a
Internal Auditor/Internal Audit Manager (with experience in Operations and/or Project Management) Location – Basel, Switzerland. Relocation assistance is available for eligible candidates and their families if needed For our small, but impactful internal audit team, we are
DTAS Strategic Advisory Consulting ( Life Sciences Supply Chain & Operations ) IQVIA is The Human Data Science Company, focused on using data and science to help healthcare clients find better solutions for their patients. IQVIA
Global Master Data Supply Chain Lead Location: San Jose, Costa Rica As the Global Master Data Supply Chain Lead, you will shape how critical supply chain master data is created, governed, and scaled across our global
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
Medical Director – Multiple Sclerosis Lead and/or support early‑stage clinical projects for multiple sclerosis, translating innovative molecules into therapies to meet unmet medical needs. Design and execute clinical development plans from Phase1 through Phase2 (proof‑of‑concept). Provide scientific
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS‑addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors